Mynvax
PrivateLast Round
Series A
Extension
May 24, 2024
Est. Valuation
$31M
Total Funding Raised
$6.8M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Mynvax is a biotechnology company that develops innovative drugs intended for use in influenza vaccines, focusing on treatments for flu and infectious diseases to support healthcare professionals in enhancing patient recovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mynvax Comparables
Compare Mynvax with similar companies based on industry and business-model similarity.
Mynvax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 24, 2024 | ||||
| Series A | Jul 19, 2021 | ||||
| Grant | Aug 1, 2020 | ||||
| Angel | Oct 18, 2018 |
Mynvax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inviga Healthcare Fund | Series A Extension |
| Kotak Mahindra Trustee | Series A |
| Kotak Investment Advisors | Series A |
| 1Crowd | Series A |
| Accel | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 214% MoM, reaching 1.3K.
- Jul 28, 2026
Monthly visitors increased 142% MoM, reaching 417.
Mynvax Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mynvax's valuation, stock price, and market status.
Is Mynvax a public or private company?
Mynvax is a private company.
What is the current stock price of Mynvax?
Mynvax is a private company with no public stock price. No recent secondary market data is available.
How much is Mynvax worth (valuation)?
Mynvax's valuation is estimated at $31.0M based on funding round data.
Can I buy Mynvax stock?
Mynvax shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mynvax's last funding round?
Mynvax's most recent funding round was Series A Extension on May 24, 2024.
Who are the main investors in Mynvax?
Key investors in Mynvax include Inviga Healthcare Fund, Accel.
Will Mynvax IPO soon?
No public IPO plans have been announced for Mynvax.
How can I track Mynvax secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mynvax's secondary market activity and sign up for updates.